Washington Trust Advisors’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.38K Sell
21
-4
-16% -$858 ﹤0.01% 584
2026
Q1
$5.49K Sell
25
-10
-29% -$2.45K ﹤0.01% 527
2025
Q4
$8.9K Buy
35
+4
+13% +$1K ﹤0.01% 507
2025
Q3
$7.58K Buy
31
+7
+29% +$1.68K ﹤0.01% 565
2025
Q2
$5.87K Hold
24
– – ﹤0.01% 553
2025
Q1
$5.54K Hold
24
– – ﹤0.01% 541
2024
Q4
$5.02K Buy
24
+2
+9% +$439 ﹤0.01% 566
2024
Q3
$5.37K Hold
22
– – ﹤0.01% 564
2024
Q2
$4.86K Hold
22
– – ﹤0.01% 562
2024
Q1
$4.97K Buy
22
+8
+57% +$1.8K ﹤0.01% 573
2023
Q4
$3.13K Hold
14
– – ﹤0.01% 624
2023
Q3
$3.13K Buy
14
+3
+27% +$679 ﹤0.01% 606
2023
Q2
$2.44K Buy
+11
New +$2.2K ﹤0.01% 617

Other funds holding STE

Washington Trust Advisors's STE Position: Q2 2026 in Review

Washington Trust Advisors reduced its Steris (STE) stake by 16% in Q2 2026, selling an estimated $858 and leaving 21 shares worth $4.38K. The position accounts for ﹤0.01% of the portfolio, ranked #584.

Washington Trust Advisors first reported a position in STE in Q2 2023 and has held it in 13 quarters since. The position peaked at $8.9K in Q4 2025. 839 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Washington Trust Advisors held 21 shares of Steris worth $4.38K as of Q2 2026.
  • Washington Trust Advisors sold 4 Steris shares in Q2 2026, an estimated $858.
  • Steris made up ﹤0.01% of Washington Trust Advisors's portfolio in Q2 2026, its #584 holding.
  • Washington Trust Advisors first reported a position in Steris in Q2 2023 and has held it in 13 quarters since.
  • Washington Trust Advisors's Steris position peaked at $8.9K in Q4 2025.
  • 839 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Washington Trust Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.